ArticleCancers2022

Anti-Anaplastic Thyroid Cancer (ATC) Effects and Mechanisms of PLX3397 (Pexidartinib), a Multi-Targeted Tyrosine Kinase Inhibitor (TKI).

Jingtao Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.